Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 285 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

8%

22 trials in Phase 3/4

Results Transparency

11%

4 of 36 completed with results

Key Signals

4 with results100% success

Data Visualizations

Phase Distribution

185Total
Not Applicable (152)
Early P 1 (2)
P 1 (2)
P 2 (7)
P 3 (8)
P 4 (14)

Trial Status

Not Yet Recruiting103
Recruiting102
Completed36
Active Not Recruiting24
Enrolling By Invitation19
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 36 completed trials

Clinical Trials (285)

Showing 20 of 20 trials
NCT07267949Phase 2RecruitingPrimary

Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation

NCT07641582Not ApplicableRecruitingPrimary

Prediction of Atrial Fibrillation Using Polygenic Risk Score

NCT06618417Not ApplicableRecruitingPrimary

Evaluating the Impact of Home-Based Sleep Apnea Diagnostic on Well-Being, Health Behavior, and AF Load in Patients With Atrial Fibrillation Using a Decentralized Platform

NCT06164808Not ApplicableRecruiting

Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch

NCT07002450Not ApplicableRecruitingPrimary

Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus in The Emergency Department (LA CLOTTED)

NCT06735001Not ApplicableRecruitingPrimary

Identification of the Metabolic Signature of Atrial Fibrillation for Personalized Prevention

NCT07633509Not ApplicableNot Yet RecruitingPrimary

The COMBINE-AF Trial

NCT07441382Not ApplicableRecruitingPrimary

Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation

NCT07633548Enrolling By Invitation

Safety And FEasibility of a Simplified Deep Sedation Protocol for Pulsed-Field Ablation

NCT07630857Not ApplicableRecruitingPrimary

Unipolar Voltage Mapping for Personalized Atrial Fibrillation Ablation

NCT06784466Not ApplicableRecruitingPrimary

Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation

NCT07626411Phase 3Not Yet RecruitingPrimary

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

NCT06615596Early Phase 1RecruitingPrimary

Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation

NCT07024927RecruitingPrimary

Complex Arrhythmia Registry

NCT07580547Not ApplicableRecruitingPrimary

Sex-Based Disparities in the Electrophysiological Substrate for Atrial Fibrillation and Its Impact on Clinical Outcomes

NCT06707688Not ApplicableActive Not RecruitingPrimary

Abbott Medical - VERITAS Study

NCT07563257Not ApplicableRecruitingPrimary

Comparative Evaluation of Optrell and Octaray Mapping Catheters for Conduction Block Confirmation and Voltage Assessment During Atrial Ablation

NCT07620262Not ApplicableRecruitingPrimary

Prospective Remapping With Concomitant Left Atrial Appendage Occlusion to Ensure Durable Electroporation Study

NCT07621432Not ApplicableNot Yet RecruitingPrimary

Deep Sedation vs. General Anesthesia for Pulsed Field Ablation in Atrial Fibrillation

NCT07618741Not ApplicableRecruitingPrimary

Improving Outcomes After AF Ablation in Obese Patients

Scroll to load more

Research Network

Activity Timeline